Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Download the App!
show episodes
 
Artwork

1
Austin Next

Jason Scharf

icon
Unsubscribe
icon
Unsubscribe
Monthly+
 
Austin's evolution into a global innovation superstar is at the heart of Austin Next. We uncover insights into the region's transformation and what it means for ecosystem building. Our exploration extends to emerging trends, technologies, and their convergence. Using Austin as our real-world case study and experts from around the world, we aim to understand the true nature and mechanics of innovation.
  continue reading
 
For biopharma pros seeking insightful discussions and a deeper understanding of the pharma world, join Dr. Na-Ri Oh and Ian Wendt as they talk with industry leaders and luminaries to delve into biotechnology, pharmaceuticals, and healthcare.RealPharma podcast aims to challenge your viewpoints, deepen your understanding of the pharma world beyond the headlines, and explore emerging trends in medical innovation.
  continue reading
 
Loading …
show series
 
The $6 trillion chemical industry is on the verge of a revolution as biology moves from the doctor's office to the industrial zone. Veronica Breckenridge, Founder and Managing Partner of First Bight Ventures, is investing in early-stage bio manufacturing companies while building the ecosystem to catalyze their growth. We discuss the tech powering t…
  continue reading
 
In this powerful and deeply human episode of RealPharma, we’re joined by Grace Magedman, PharmD—former Chief Pharmacy Officer at Children’s Hospital of Orange County, functional medicine practitioner, and founder of The Magidman Group. Grace takes us inside her 20+ years of hospital pharmacy leadership, where she navigated high-stakes medication de…
  continue reading
 
At a hinge point when tech leadership determines the balance of geopolitical power, deep tech investment has never been more critical to America's future. Jordan Blashek, co-founder of America's Frontier Fund, brings his perspective on innovation for national advantage. From investing in defense tech to the newly launched Endless Frontiers, we disc…
  continue reading
 
From cutting-edge chips to AI networks the disruption happening up and down the tech stack is upending invention and value. Everything is on the table. Tyson Tuttle, former CEO of Silicon Labs and current founder and CEO of Circuit, brings decades of experience building innovative products across multiple tech waves. In this conversation, Tyson sha…
  continue reading
 
The Texas innovation ecosystem is accelerating at breakneck speed as technologies like AI and institutions such as the Texas Stock Exchange reshape what is possible. Samantha Lewis, Partner at Mercury Fund, recently relocated to Austin from Houston to strengthen the firm's presence in the region. Our conversation reveals how the founders and funder…
  continue reading
 
In this second part of our deep dive into hematology and oncology, we welcome back Dr. Yaming Wang, founder of Alphabet Health LTD and an expert in molecular oncology, pharmaceutical strategy, and medical education. Building on our previous discussion, we explore cutting-edge advancements in cancer diagnostics and therapies, including the promise a…
  continue reading
 
🎙 RealPharma Podcast – Oncology Part 1: Understanding the Cancer Universe with Dr. Yaming Wang Cancer is one of the most complex and pressing challenges in modern medicine. But how much do we really understand about it? In this first episode of our two-part oncology deep dive, we sit down with Dr. Yaming Wang, founder of Alphabet Health, to break d…
  continue reading
 
Technology is advancing rapidly, but our social systems and institutions struggle to keep pace. Janine Leger co-founded Edge City, a society incubator accelerating social innovation through popup and experimental communities, and they're bringing their next gathering to Austin March 2-7. We explore how rethinking the intersection of technology and …
  continue reading
 
A unicorn biopharma that ignores the traditional playbook, breaks development speed records, and chose Austin over the traditional biotech hubs. Mallory Factor, Founder and CEO of IntraBio, joins us to share how his Oxford-born company created an FDA-approved drug in record time while doing everything differently. In this wide-ranging conversation,…
  continue reading
 
A coffee conversation turned into a deep exploration and personal obsession about how we shape our world and how it shapes us. I had to invite my partner in that conversation, Dr. Gena Gorlin, on to the podcast to bring her perspective as a psychologist, professor, and founder coach to examine the interplay between agency, innovation, ecosystems, a…
  continue reading
 
In this episode of Real Pharma, hosts Na-Ri Oh and Ian Wendt engage with Joshua Kettner, co-founder of DreamBody Clinic, to explore the intricacies of stem cell therapy. They discuss the clinic's unique approach to regenerative medicine, the science behind mesenchymal stem cells, and the various applications and limitations of this therapy. The con…
  continue reading
 
Last June, SXSW announced they would no longer allow military and defense companies as sponsors. This sparked strong reactions from Austin's defense tech community, with one of those reactions leading to the creation of Austin4America. I'm joined by Luke Fischer, one of the summit's creators, to discuss why this matters and how it fits into Austin'…
  continue reading
 
In this riveting episode of RealPharma, hosts Na-Ri Oh and Ian Wendt sit down with the renowned ethnopharmacologist, Dennis McKenna, to explore the profound intersection of nature, science, and healing. From Dennis’s storied journey into the world of plant medicines to the evolving landscape of psychedelic therapies, this conversation is as thought…
  continue reading
 
This past November, the University of Austin hosted their Inaugural SOMA Summit to explore the amazing transformation in space right now, especially how the commercial space era is decentralizing access. I had the privilege to moderate a fascinating panel titled "Science in the Commercial Space Age" featuring Chris Sembroski from Blue Origin, along…
  continue reading
 
Year-End Wrap-Up with Kristiaan Rawlings In this episode of the Real Pharma Podcast, hosts Ian Wendt and Na-Ri Oh welcome back frequent guest Kristiaan Rawlings, a seasoned commercial pharmaceutical recruiter, for a year-end reflection on the pharmaceutical job market in 2024 and a look ahead to 2025. The discussion highlights key trends, challenge…
  continue reading
 
AI is becoming the biggest force multiplier for human talent in history. Austen Allred shares how Gauntlet AI is reimagining engineering education for this new reality and why Austin's is the perfect place to build this ambitious program. This is was quick turnaround episode as Gauntlet AI applications close January 4th (application link below). We…
  continue reading
 
In this episode of the Real Pharma Podcast, hosts Ian Wendt and Dr. Na-Ri Oh and guest Jason Scharf delve into the evolving landscape of TechBio, exploring its definition, the rise of bio innovation, and the challenges and opportunities it presents. They discuss the shift from traditional drug development methods to innovative approaches driven by …
  continue reading
 
Space is becoming our next great innovation frontier as we move from 700 astronauts spending days or months to tens of thousands spending years. What does that do to the human body? What does it mean for our species? Eliah Overbey, Assistant Professor of Bioastronautics at the University of Austin, joins the podcast to explore topics in the increas…
  continue reading
 
Austin is rapidly emerging as a significant edtech hub, attracting not just innovative startups but also established industry leaders. In this episode, Udemy's Chief Revenue Officer Rob Rosenthal joins me to explore what skills are in-demand and how technology is transforming both what we learn and how we learn it. Episode Highlights Generational C…
  continue reading
 
In this conversation, Roger Estafanos discusses the evolving field of radiopharmaceuticals, highlighting their transformative impact on cancer treatment and patient care. He explains the targeted nature of these therapies, the importance of personalized medicine, and the challenges faced in regulatory processes and patient safety. The discussion al…
  continue reading
 
Recorded live at Austin's Quantonation Day this past September, I sat down with senior leaders from Strangeworks, Qunnect, Pasqal, and Tau Systems to discuss the state of quantum and physics tech. This candid panel went beyond the typical quantum computing conversation to face the market realities of building a business in the space. We explored th…
  continue reading
 
In this conversation, Aaron Burnett, from Wheelhouse DMG, discusses the rapid evolution of digital marketing in the healthcare sector, emphasizing the importance of data strategy and compliance with regulations like HIPAA. He highlights the shift from third-party data reliance to first-party data utilization, which enhances marketing effectiveness …
  continue reading
 
Optimizing health is about more than just new tech, it's about new models, new ways to engage, and being fun. Jim Donnelly, founder and CEO of Humanaut Health, is pioneering a comprehensive approach that combines advanced diagnostics, the latest interventions, with lifestyle changes to add decades of healthy living to people's lives. In this episod…
  continue reading
 
Building companies that can 10x humanity requires extraordinary leadership. Craig Cummings of Moonshots Capital has made finding and backing these leaders his mission. Craig shares his insights on building the next generation of mission-driven companies and the future of the Austin ecosystem. Episode Highlights What is a Moonshot? Finding the %$^* …
  continue reading
 
In this latest episode of RealPharma, we’re diving back into the fascinating world of AI in pharma, breaking down all the insights from our conversation with the brilliant Andree Bates! If you missed it or want to catch the highlights, this episode serves up a concise, punchy summary covering everything from predictive analytics to patient outcomes…
  continue reading
 
In this episode, Dr. Na-Ri Oh and Ian Wendt sit down with Philip Vyt, a renowned expert in omnichannel strategy and founder of Shyft, a consultancy specializing in omnichannel approaches for biopharma. They delve into the key concepts behind omnichannel and its distinction from multichannel, emphasizing the centrality of healthcare professionals (H…
  continue reading
 
In this episode, Dr. Na-Ri and Ian Wendt welcome back Kristiaan Rawlings, from EPM Scientific to discuss the latest trends in pharma and biotech hiring. They explore the key drivers of hiring, the impact of AI and advanced analytics, and the evolving expectations of candidates. Kristiaan emphasizes the importance of change agents in the industry an…
  continue reading
 
Nothing motivates a parent to action like a sick child, and for the Andrews family, words like no and impossible became mere roadblocks on their journey to help their kids. Our guests, Pam and Chris Andrews, founders of the Firefly Fund, turned their battle with their daughters' rare genetic disorder into a mission to revolutionize rare disease res…
  continue reading
 
Angel investors are supposed to descend and bring early grace to startups but the reality of angel investing is much more complicated and complex. From individual big-check writers to small investors to organized groups, the will, experience, and dynamics vary widely. Katie Russel (Central Texas Angel Network), Hall Martin (Ten Capital), and James …
  continue reading
 
In this episode, Ian Wendt and Dr. Na-Ri Oh interview Michael C. Barnes, Chairman of the Center for US Policy, about the US opioid crisis. They discuss the evolution of US policy on opioids, the impact of the crisis on different communities, the role of legislation and harm reduction, the accountability of the pharmaceutical industry, barriers to a…
  continue reading
 
Are we overlooking the most powerful model of intelligence we have in our race to create smarter machines, the human mind? Peter Voss, CEO and Chief Scientist of Aigo.ai, coined the term "Artificial General Intelligence" (AGI) and brings decades of experience in AI research and development. We explore Peter's vision and challenge the current consen…
  continue reading
 
What connects the Startup Nation to the Lone Star State? We're witnessing a growing nexus that crosses tech, cultures, and economic verticals. To explore this emerging relationship, I'm joined by Tal Shmueli and Simone Ledeen from Texas Venture Partners. They're at the forefront of catalyzing this intersection between two innovative ecosystems. Epi…
  continue reading
 
Danny McBryan, an executive leader in the pharmaceutical industry, discusses the evolving role of medical affairs in healthcare. He highlights the importance of medical affairs in conveying the science of pharmaceutical companies and translating complex data into a meaningful narrative for healthcare providers, payers, patients, and policymakers. M…
  continue reading
 
From wargaming to Riskgaming, what can simulations and stories teach us about the future of technology and innovation? Danny Crichton, Head of Editorial and Risk Gaming at Lux Capital, brings his unique insights from his experience in both tech journalism and venture capital. What started as a conversation on the tech-media divide expanded to encom…
  continue reading
 
In this episode, Na-Ri and Ian interview Stacey Tinianov, an independent patient advocate and founder of Advocates for Collaborative Education. They discuss the importance of patient advocacy, the role of digital health, and the future of patient engagement. Stacey shares her personal journey into patient advocacy and highlights the gaps in knowled…
  continue reading
 
Is venture capital on the cusp of a data-driven revolution? Gopinath Sundaramurthy, Founder & Head of Data Science at Ensemble VC, believes AI and advanced analytics are reshaping how VCs identify and support promising startups. From transforming deal pipelines to finding diamonds in the rough around the globe, we explore what this new era will mea…
  continue reading
 
Can the stories we tell shape the future we build? Devon Eriksen, author of "Theft of Fire" and now Dragon Award finalist, argues that science fiction isn't just entertainment; it's a catalyst for innovation and human progress. Our narratives can be beautiful and optimistic, inspiring us to build, or ugly and pessimistic, causing us to stagnate. It…
  continue reading
 
Summary Dr. Andrée Bates, a pioneering force in the realm of artificial intelligence within the pharmaceutical industry, shares insights on the evolving role of AI in pharma, the future of healthcare innovation, and her advocacy for women in leadership. She discusses the early days of AI in pharma, the challenges faced, and the evolution of AI term…
  continue reading
 
Evan Loomis, partner at Overmatch Ventures and co-founder of ICON, exemplifies Austin's entrepreneurial spirit in tackling audacious challenges. From revolutionizing construction to investing in frontier technologies, Evan shares his journey through Austin's rapidly evolving tech landscape and why now is the moment for critical tech. We don't shy a…
  continue reading
 
Can a city’s food scene serve as a catalyst for connection, creativity, and innovation? Grace Chow, Co-Founder & CEO of Austin-based Lobos Hospitality, joins me to share her insights from food scenes across the US, and her in-the-trenches view from building three distinctive Austin restaurants: Toasty Badger, Manny's, and the Powder Room. Episode H…
  continue reading
 
Summary In this episode, Dr. Na-Ri Oh and Ian Wendt discuss Pharmacy Benefit Managers (PBMs) and their impact on drug pricing and patient access to medications. They are joined by Antonio Ciaccia, CEO of 46 Brooklyn Research and president of 3 Access Advisors, which provides insights into the role of PBMs in the drug supply chain. The conversation …
  continue reading
 
In this episode, Dr. Na-Ri Oh and Ian Wendt discuss the 340B drug pricing program with guest William Sarraille, a healthcare law expert. They explore the origins of the program and its intended purpose. However, the program has grown exponentially and is now the second largest drug program in the country. Bill raises concerns about the lack of tran…
  continue reading
 
Promising startups often fail despite following best practices, while rule-breakers and those running through chaos can achieve massive success. Why? Mike Maples Jr, Founding Partner at Floodgate, tackles this paradox in his book "Pattern Breakers." We discuss his Inflection Theory, why some pivots work and others don't, unexpected inspirations lik…
  continue reading
 
What do global trends affects on startups, the art of selling, startup accelerators, and the future lizard king all have in common? They are all just a few of the diverse and intersecting topics that I explore today with Joe Merrill, Co-Founder and Partner at Sputnik VC. Episode Highlights Sputnik ATX invests in pre-seed startups across various sec…
  continue reading
 
Summary Dr. Ron Shigeta, a pioneer in the biotech startup ecosystem, shares his insights and experiences in this episode. He discusses the success of IndieBio, a biotech accelerator that demonstrated the potential of modest investments in fueling biotech innovations. Dr. Shigeta also highlights the importance of timing, luck, and having a clear vis…
  continue reading
 
In honor of the The Board Walks' 100th walk this past weekend, we are rereleasing our episode with Board Walks Founder Elle Beecher. Episode Originally Aired September 12, 2023 ---------------------- Fostering connectivity within an innovation ecosystem is crucial for its ongoing vitality and growth. Often revolutionary concepts emerge from the mos…
  continue reading
 
In this enlightening episode of the RealPharma Podcast, hosts Ian Wendt and Dr. Nari Oh sit down with Dr. Steven King, a luminary in the field of ethnobotanical research and sustainable pharmaceutical development. Dr. King, currently serving as the Chief Sustainable Supply, Ethnobotanical Research, and IP Officer at Jaguar Health, shares his remark…
  continue reading
 
The future of defense and warfare has always been linked to technological change, from the discovery of fire to the Bronze Age to the Nuclear Age to now the AI Age. My guest today is Charlie Burgoyne, Founder and CEO of both Valkyrie and their newest spinout Andromeda, who joins me to discuss the future of warfare going forward. But we don't stop t…
  continue reading
 
The only constant in Austin seems to be change. Whether that be the people moving here, the buildings defining our skyline, or the startups being founded and funded. Today, my guest is Krishna Srinivasan, founding Partner of LiveOak Ventures. We will explore what it means to invest in Texas startups yesterday, today, and tomorrow. Episode Highlight…
  continue reading
 
Command the Room: Dr. Laura Sicola's Strategies for Executive Communication Excellence Hosts: Dr. Na-Ri Oh and Ian Wendt In this episode of the Real Pharma Podcast, we delve into the intricacies of effective executive communication with Dr. Laura Sicola, a renowned expert in leadership communication and cognitive linguistics. Dr. Sicola has spent o…
  continue reading
 
Loading …
Listen to this show while you explore
Play